Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Recently, Pfizer has launched a specialised centre at a hospital in Gurugram and is planning to start more such centres to ...

Stake sale - Read all the latest news headline updates on Stake sale. Get all the Stake sale breaking news updates, videos, photostories and more at Business Standard.

Global sarcopenia treatment market was valued USD 3.07 billion in 2023, growing at a compound annual growth rate (CAGR) of 4.48% during the forecast period 2024-2032. Read the Market Summary Here @ ...

A total of 739 deals were completed so far this year representing a decrease of just under 21 per cent compared to last year.

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

It would be the market’s largest deal since GSK and Pfizer spun off healthcare giant Haleon in 2022. London has attracted ...

During the same period, the company received roughly $6.9 billion of net cash proceeds from the sale of its shares of Haleon, a consumer health joint venture with GSK. In Pfizer's Q3 earnings call ...

Haleon backed its full-year guidance despite ... healthcare business—which was spun out of GSK and is partly owned by Pfizer—said Thursday that revenue for the quarter was 2.78 billion pounds ...